Form 483

Philips Respironics, Inc. Form 483, 2022-05-19

FDA issued a Form 483 to Philips Respironics, Inc. on 2022-05-19 with 4 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health4 observations

Philips Respironics, Inc. · Murrysville, United States · Issued May 19, 2022

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 May 2022
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Christine I Shaw, Joshua E Yao

19 May 2022
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Christine I Shaw, Joshua E Yao

19 May 2022
21 CFR 820.40

Procedures not adequately established or maintained

Cited by Christine I Shaw, Joshua E Yao

19 May 2022
21 CFR 820.40

Procedures not adequately established or maintained

Cited by Christine I Shaw, Joshua E Yao

Inspected site

PRPhilips Respironics, Inc.Murrysville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations2x
21 CFR 820.40Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere